Photodynamic therapy for actinic cheilitis: A systematic review

Dermatologic Surgery

Volumn 41, Issue 2, 2015, Pages 189-198

  Yazdani Abyaneh, Mohammad Ali ^a   Falto Aizpurua, Leyre ^a   Griffith, Robert D ^a   Nouri, Keyvan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CODEINE PHOSPHATE; DICLOFENAC; DICLOXACILLIN; DIPYRONE; EMOLLIENT AGENT; FAMCICLOVIR; FLUOROURACIL; IMIQUIMOD; LUBRICATING AGENT; MEPIVACAINE; PARACETAMOL; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACTINIC CHEILITIS; ARTICLE; BURN; CARBON DIOXIDE LASER; CASE STUDY; CHEILITIS; CRYOSURGERY; DRY SKIN; DYE LASER; EDEMA; ERBIUM YAG LASER; EROSION; ERYTHEMA; FOLLOW UP; HERPES LABIALIS; HISTOLOGY; HUMAN; META ANALYSIS; ORAL BLISTER; OUTCOME ASSESSMENT; PAIN; PARESTHESIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PULSED DYE LASER; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE; VERMILIONECTOMY; XEROSTOMIA; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ESTHETICS; PATHOLOGY; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; CHEILITIS; ESTHETICS; HUMANS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME;

EID: 84922675848     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1097/DSS.0000000000000254     Document Type: Article

References (53)

1. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol 2012;66:173-84.
2. Main JH, Pavone M. Actinic cheilitis and carcinoma of the lip. J Can Dent Assoc 1994;60:113-6.
3. Wurman LH, Adams GL, Meyerhoff WL. Carcinoma of the lip. Am J Surg 1975;130:470-4.
4. Baker SR. Risk factors in multiple carcinomas of the lip. Otolaryngol Head Neck Surg (1979) 1980;88:248-51.
5. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004;10:212-6.
6. Nicolau SG. Chronic actinic cheilitis of the lower lip and the possibilities of its evolution toward precancerous and cancerous states [in Romanian]. Rev Med Chir Soc Med Nat Iasi 1968;72:9-14.
7. Zitsch RP, Lee BW, Smith RB. Cervical lymph node metastases and squamous cell carcinoma of the lip. Head Neck 1999;21:447-53.
8. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, et al. Survival after lip cancer diagnosis. J Craniofac Surg 2009;20:248-52.
9. Czerninski R, Zini A, Sgan-Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970-2006. Br J Dermatol 2010;162:1103-9.
10. Guntinas-Lichius O, Wendt T, Buentzel J, Esser D, et al. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 2010;136:55-63.
11. Abreu L, Kruger E, TennantM. Lip cancer in Western Australia, 1982-2006: a 25-year retrospective epidemiological study. Aust Dent J 2009; 54:130-5.
12. Hasson O. Squamous cell carcinoma of the lower lip. J Oral Maxillofac Surg 2008;66:1259-62.
13. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994;131:455-64.
14. Sotiriou E, Apalla Z, Koussidou-Erremonti T, Ioannides D. Actinic cheilitis treated with one cycle of 5-aminolaevulinic acid-based photodynamic therapy: report of 10 cases. Br J Dermatol 2008;159: 261-2.
15. Kaugars GE, Pillion T, Svirsky JA, Page DG, et al. Actinic cheilitis: a review of 152 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:181-6.
16. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:8-10.
17. Menta Simonsen Nico M, Rivitti EA, Lourenco SV. Actinic cheilitis: histologic study of the entire vermilion and comparison with previous biopsy. J Cutan Pathol 2007;34:309-14.
18. Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol 1996;35:223-42.
19. MacFarlane GE, Terezhalmy GT. Actinic cheilitis. Diagnosis, prevention, and treatment. US Navy Med 1982;73:22-4.
20. Dufresne RG Jr, Curlin MU. Actinic cheilitis. A treatment review. Dermatol Surg 1997;23:15-21.
21. Vinciullo C. Combination carbon dioxide laser vermilionectomy and wedge excision of the lip. Australas J Dermatol 1996;37:111-2.
22. Cavalcante AS, Anbinder AL, Carvalho YR. Actinic cheilitis: clinical and histological features. J Oral Maxillofac Surg 2008;66:498-503.
23. Bentley JM, Barankin B, Lauzon GJ. Paying more than lip service to lip lesions. Can Fam Physician 2003;49:1111-6.
24. Satorres Nieto M, Gargallo Albiol J, Gay Escoda C. Surgical management of actinic cheilitis [in English, Spanish]. Med Oral 2001;6: 205-17.
25. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor. Part II: Therapeutic perspectives. J Am Acad Dermatol 2012;66:187-98.
26. Whitaker DC. Microscopically proven cure of actinic cheilitis by CO2 laser. Lasers Surg Med 1987;7:520-3.
27. Robinson JK. Actinic cheilitis. A prospective study comparing four treatment methods. Arch Otolaryngol Head Neck Surg 1989;115: 848-52.
28. de Godoy Peres FF, Aigotti Haberbeck Brandão A, Rodarte Carvalho Y, Dória Filho U, et al. A study of actinic cheilitis treatment by two low-morbidity CO2 laser vaporization one-pass protocols. Lasers Med Sci 2009;24:375-85.
29. Shah AY, Doherty SD, Rosen T. Actinic cheilitis: a treatment review. Int J Dermatol 2010;49:1225-34.
30. Cullen SI. Topical fluorouracil therapy for precancers and cancers of the skin. J Am Geriatr Soc 1979;27:529-35.
31. Greenberg HL, Cohen JL, Rosen T, Orengo I. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes. J Drugs Dermatol 2007;6:452-8.
32. Smith KJ, Germain M, Yeager J, Skelton H. Topical 5% imiquimod for the therapy of actinic cheilitis. J Am Acad Dermatol 2002;47: 497-501.
33. Chakrabarty AK, Mraz S, Geisse JK, Anderson NJ. Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis. J Am Acad Dermatol 2005;52:35-7.
34. Warnock GR, Fuller RP Jr, Pelleu GB Jr. Evaluation of 5-fluorouracil in the treatment of actinic keratosis of the lip. Oral Surg Oral Med Oral Pathol 1981;52:501-5.
35. Epstein E. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil. Arch Dermatol 1977;113:906-8.
36. Larko O. The current options in the management of actinic keratosis. G Ital Dermatol Venereol 2009;144:445-52.
37. Levi A, Wulf HC, Enk CD. Two cases of actinic cheilitis responsive to daylight-activated photodynamic therapy (DA-PDT). Photodermatol Photoimmunol Photomed 2013;29:268-71.
38. Castaño E, Comunión A, Arias D,Miñano R, et al. Photodynamic therapy for actinic cheilitis [in Spanish]. Actas Dermosifiliogr 2009;100:895-8.
39. Alexiades-ArmenakasMR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol 2004;3:548-51.
40. Fai D, Romano I, Cassano N, Vena GA. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients. G Ital Dermatol Venereol 2012;147:99-101.
41. Sotiriou E, Apalla Z, Chovarda E, Panagiotidou D, et al. Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up. J Eur Acad Dermatol Venereol 2010; 24:916-20.
42. Sotiriou E, Lallas A, Goussi C, Apalla Z, et al. Sequential use of photodynamic therapy and imiquimod 5%cream for the treatment of actinic cheilitis: a 12-month follow-up study. Br J Dermatol 2011;165:888-92.
43. Berking C, Herzinger T, Flaig MJ, Brenner M, et al. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg 2007;33:825-30.
44. Stender IM, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996;135:454-6.
45. Zaiac M, Clement A. Treatment of actinic cheilitis by photodynamic therapy with 5-Aminolevulinic acid and blue light activation. J Drugs Dermatol 2011;10:1240-5.
46. Ribeiro CF, Souza FH, Jordão JM, Haendchen LC, et al. Photodynamic therapy in actinic cheilitis: clinical and anatomopathological evaluation of 19 patients. An Bras Dermatol 2012;87:418-23.
47. Calzavara-Pinton PG, Rossi MT, Sala R. A retrospective analysis of reallife practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Photochem Photobiol Sci 2013;12:158-65.
48. Rossi R, Assad GB, Buggiani G, Lotti T. Photodynamic therapy: treatment of choice for actinic cheilitis? Dermatol Ther 2008;21:412-5.
49. Hauschild A, Lischner S, Lange-Asschenfeldt B, Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methylaminolevulinate: report of three cases. Dermatol Surg 2005;31: 1344-7.
50. Kodama M, Watanabe D, Akita Y, Tamada Y, et al. Photodynamic therapy for the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed 2007;23:209-10.
51. McDonald C, Laverick S, Fleming CJ, White SJ. Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients. Br J OralMaxillofac Surg 2010; 48:473-6.
52. Castiñeiras I, Del Pozo J, Mazaira M, Rodríguez-Lojo R, et al. Actinic cheilitis: evolution to squamous cell carcinoma after carbon dioxide laser vaporization. A study of 43 cases. J Dermatolog Treat 2010;21:49-53.
53. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008;158:740-6.